butyric acid and n-formylmethionine leucyl-phenylalanine

butyric acid has been researched along with n-formylmethionine leucyl-phenylalanine in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's2 (66.67)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Akutagawa, H; Kim, KM; Mayumi, M; Mikawa, H; Morita, M; Nambu, M; Ohshima, Y; Uenoyama, Y1
Johnson, DW; Liotta, LA; Neckers, LM; Thorgeirsson, UP; Turpeenniemi-Hujanen, T1
Fujii, K; Hamamura, I; Kishimoto, T; Mitsuhashi, H; Muratani, E; Nonaka, T1

Other Studies

3 other study(ies) available for butyric acid and n-formylmethionine leucyl-phenylalanine

ArticleYear
Dibutyryl cyclic AMP induces formyl peptide receptor expression and chemotactic responses in a human eosinophilic cell line, EoL-1.
    Experimental hematology, 1991, Volume: 19, Issue:8

    Topics: Actins; Bucladesine; Butyrates; Butyric Acid; Calcium; Cell Differentiation; Cell Division; Cell Line; Chemotaxis, Leukocyte; Complement C5a; Eosinophils; Humans; N-Formylmethionine Leucyl-Phenylalanine; Platelet Activating Factor; Polymers; Receptors, Formyl Peptide; Receptors, Immunologic; Time Factors

1991
Protein synthesis but not DNA synthesis is required for tumor cell invasion in vitro.
    Invasion & metastasis, 1984, Volume: 4, Issue:2

    Topics: Amnion; Animals; Aphidicolin; Butyrates; Butyric Acid; Cell Division; Cell Line; Collagen; Cycloheximide; Diterpenes; DNA, Neoplasm; Humans; Lymphoma, Large B-Cell, Diffuse; Mice; N-Formylmethionine Leucyl-Phenylalanine; Neoplasm Invasiveness; Neoplasm Proteins; Neoplasms, Experimental

1984
Pharmacological activities of TEI-8362, a novel inhibitor of human neutrophil elastase.
    British journal of pharmacology, 1999, Volume: 126, Issue:5

    Topics: Animals; Butyrates; Butyric Acid; Carbamates; Cricetinae; Enzyme Inhibitors; Humans; Leukocyte Elastase; Lipopolysaccharides; Male; Mesocricetus; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Protective Agents; Respiratory Distress Syndrome; Substrate Specificity

1999